Impairment of antioxidant defenses as a contributor to arsenite-induced cell transformation
- 13 June 2012
- journal article
- research article
- Published by Springer Science and Business Media LLC in BioMetals
- Vol. 25 (5), 927-937
- https://doi.org/10.1007/s10534-012-9559-1
Abstract
Arsenite (As) causes transformation of human osteogenic sarcoma cells (HOS) when applied continuously at low doses (0.1–0.5 μM) during 8-weeks of exposure. However, the mechanisms by which As transforms human cells are not known. We investigated whether alterations occurred in gene expression and protein levels of antioxidant defense proteins, such as superoxide dismutase 1 (SOD1) and ferritin. In comparison to control HOS cells, 0.1 μM As induced greater cell proliferation and decreased anti-oxidant defenses. The tumor suppressor protein p53 was also decreased at both mRNA and protein levels. Further, pig3 (p53-induced-gene 3), a homolog of NQO1 (NADPH quinone oxidoreductase 1), was also down-regulated after 8 weeks of As challenge. The treatment of HOS cells with dicumarol, a NQO1 inhibitor, caused a dose-dependent decline in p53 protein levels, proving the effect of an antioxidant enzyme on p53 expression and, potentially, down-stream processes. Caffeic acid phenethyl ester, an antioxidant, prevented the As-induced decreases in SOD1, p53, and ferritin mRNA and protein levels. SOD1, p53 and ferritin levels were inversely related to As-induced cell proliferation. Cumulatively, these results strongly suggest that impairment in antioxidant defenses contributes to As-induced human cell transformation and that the p53 pathway is involved in the process.Keywords
This publication has 40 references indexed in Scilit:
- Reduced Reactive Oxygen Species–Generating Capacity Contributes to the Enhanced Cell Growth of Arsenic-Transformed Epithelial CellsCancer Research, 2010
- Genetic and Epigenetic Mechanisms in Metal Carcinogenesis and Cocarcinogenesis: Nickel, Arsenic, and ChromiumChemical Research in Toxicology, 2007
- Further evidence against a direct genotoxic mode of action for arsenic-induced cancerToxicology and Applied Pharmacology, 2007
- Altered iron homeostasis involvement in arsenite-mediated cell transformationFree Radical Biology & Medicine, 2006
- Caffeic acid phenethyl ester (CAPE) prevents transformation of human cells by arsenite (As) and suppresses growth of As-transformed cellsToxicology, 2005
- L-methionine reduces oxidant stress in endothelial cells: Role of heme oxygenase-1, ferritin, and nitric oxideThe AAPS Journal, 2005
- Arsenite induces delayed mutagenesis and transformation in human osteosarcoma cells at extremely low concentrationsEnvironmental and Molecular Mutagenesis, 2003
- Induction of ferritin and lipid peroxidation by coal samples with different prevalence of coal workers' pneumoconiosis: Role of iron in the coalsAmerican Journal of Industrial Medicine, 2002
- Arsenic Disrupts Cellular Levels of p53 and mdm2: A Potential Mechanism of CarcinogenesisBiochemical and Biophysical Research Communications, 1999
- Characterization and accumulation of ferritin in hepatocyte nuclei of mice with iron overloadJournal of Hepatology, 1990